Keyphrases
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
37%
Cell-free DNA (cfDNA)
19%
Chemotherapy
27%
Chronic Lymphocytic Leukemia
26%
Confidence Interval
30%
Denmark
17%
Diffuse Large B-cell Lymphoma (DLBCL)
100%
Follicular Lymphoma
25%
High Risk
21%
High-risk Human Papillomavirus (HR-HPV)
21%
International Prognostic Index
39%
Lymphoma
42%
Lymphoma Patients
70%
Mantle Cell Lymphoma
44%
Non-Hodgkin Lymphoma
23%
Overall Survival
18%
Poor Outcome
22%
Progression-free Survival
22%
R-CHOP
25%
Remission
15%
Rituximab
27%
Young Patients
18%
Medicine and Dentistry
Autologous Stem Cell Transplantation
34%
B-Cell Chronic Lymphocytic Leukemia
15%
Diagnosis
15%
Diffuse Large B-Cell Lymphoma
65%
Diseases
57%
Genital Wart
15%
International Prognostic Index
29%
Mantle Cell Lymphoma
34%
Mantle Cell Lymphoma International Prognostic Index
21%
Non-Hodgkin Lymphoma
21%
Placebo
18%
Prognostic Factor
19%
Rituximab
23%
Wart Virus
31%
Wart Virus Vaccine
18%
